中东和非洲骨关节炎治疗市场预测至 2030 年 - 区域分析 - 按治疗类型（经皮神经电刺激 (TENS)、职业治疗、物理治疗、富血小板血浆治疗和基质血管成分、增生疗法等）、疾病适应症（膝关节骨关节炎、脊柱骨关节炎、足部和踝关节骨关节炎、肩部骨关节炎、手部骨关节炎等）和最终用户（医院和诊所、专科诊所、门诊手术中心、家庭护理等）
骨关节炎患病率上升促进中东和非洲骨关节炎治疗市场发展
根据 CDC 报告，全球 OA 影响超过 5 亿人，占世界人口的 7%。它是长期残疾的主要原因。此外，骨关节炎在运动员和遭受关节损伤或创伤的人群中也更为常见。此外，它在女性中更为常见，占全球骨关节炎病例的 60%。根据世界卫生组织 (WHO) 的报告，骨关节炎在老年人群中更为常见。此外，OA 可以影响任何人，但这种疾病在 40 岁以上的成年人中最为常见。此外，世界卫生组织的报告进一步显示，约 73% 的 OA 患者年龄超过 55 岁，其中 60% 为女性。因此，随着 OA 患病率的上升，生物疗法等新疗法正受到全世界的关注。富血小板血浆 (PRP) 疗法就是一个例子，它已成为 OA 患者的一种有前途的治疗方法。PRP 通过催化身体的自然愈合和组织修复过程来增强组织恢复。
经皮神经电刺激 (TENS) 是治疗 OA 的另一种治疗方法。TENS 通过减少对药物的需求来帮助最大限度地减轻急性和慢性疼痛。因此，OA 患病率的上升加速了对创新治疗方案的需求，从而减少了未来几年对药物的依赖。
中东和非洲骨关节炎治疗市场概览
中东和非洲地区分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区国家。肥胖率上升、生活方式改变和饮食习惯是导致中东和非洲地区对骨关节炎药物需求加速增长的最重要因素。根据美国国立卫生研究院 (NIH) 的报告，骨关节炎是最常见的关节炎形式。在南非，城市地区骨关节炎发病率为 55.1%；农村地区发病率为 29.5% 至 29.7%，65 岁以上人口发病率高达 82.7%。医生建议采用多种治疗方案来治疗骨关节炎。治疗方法包括非甾体抗炎药 (NSAID)，如布洛芬。因此，骨关节炎治疗方案的可用性是 2022-2030 年市场增长的主要因素。
中东和非洲骨关节炎治疗市场收入和预测到 2030 年（百万美元）
中东和非洲骨关节炎治疗市场细分
中东和非洲骨关节炎治疗市场分为治疗类型、疾病适应症、最终用户和国家。
根据治疗类型，中东和非洲骨关节炎治疗市场细分为经皮电神经刺激 (TENS)、职业治疗、物理治疗、富血小板血浆 (PRP) 治疗和基质血管分数、增生疗法等。 2022 年，物理治疗领域占据了最大的市场份额。
就疾病适应症而言，中东和非洲骨关节炎治疗市场细分为膝关节骨关节炎、脊柱骨关节炎、足踝骨关节炎、肩关节骨关节炎、手部骨关节炎等。2022 年，膝关节骨关节炎领域占据了中东和非洲骨关节炎治疗市场的最大份额。
根据最终用户，中东和非洲骨关节炎治疗市场分为医院和诊所、专科诊所、门诊手术中心、家庭护理等。2022 年，家庭护理领域占据了中东和非洲骨关节炎治疗市场的最大份额。
按国家/地区划分，中东和非洲骨关节炎治疗市场细分为南非、沙特阿拉伯、阿联酋和中东及非洲其他地区。 2022 年，南非占据了中东和非洲骨关节炎治疗市场的主导份额。
Estar Technologies Ltd、Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc 和 Medi GmbH & Co KG 是中东和非洲骨关节炎治疗市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. Middle East & Africa Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - Middle East & Africa Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Osteoarthritis Therapy Market - Country Analysis
10.1 Middle East & Africa Market Overview
10.1.1 Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.4.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.4.5 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Estar Technologies Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DePuy Synthes Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bioventus Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Omron Healthcare Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medi GmbH & Co KG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
List of Tables
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Organic Developments Done by Companies
Table 16. Inorganic Developments Done by Companies
List of Figures
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 26. Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Osteoarthritis Therapy Market
1. Estar Technologies Ltd
2. Zimmer Biomet Holdings Inc
3. DePuy Synthes Inc
4. Bioventus Inc
5. Omron Healthcare Inc
6. Medi GmbH & Co KG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa osteoarthritis therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa osteoarthritis therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.